CIK 0001157075 · Non-accelerated filer<br>Smaller reporting company
PharmaCyte Biotech, Inc.
Sign in to watch- Ticker
- PMCB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 621772151
- Phone
- (917) 595.2850
- Business address
- 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169
- Former names
- NUVILEX, INC., EFOODSAFETY COM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | WALKER WAYNE REMELL Director | Other acquisition · Stock Option (Right to Buy) | +0 | 0 | ||
| 2026-03-31 | Abecassis Michael M Director | Other acquisition · Stock Option (Right to Buy) | +0 | 0 | ||
| 2026-03-31 | SCHECHTER JONATHAN Director | Other acquisition · Stock Option (Right to Buy) | +0 | 0 | ||
| 2026-03-31 | WEINSTEIN ROBERT Director | Other acquisition · Stock Option (Right to Buy) | +0 | 0 | ||
| 2026-03-31 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +119,170 | 119,170 | ||
| 2026-03-31 | WALKER WAYNE REMELL Director | Grant or award · Stock Option (Right to Buy) | +119,170 | 119,170 | ||
| 2026-03-31 | SCHECHTER JONATHAN Director | Grant or award · Stock Option (Right to Buy) | +119,170 | 119,170 | ||
| 2026-03-31 | Abecassis Michael M Director | Grant or award · Stock Option (Right to Buy) | +119,170 | 119,170 | ||
| 2026-01-07 | Silverman Joshua CEO and President | Purchase | +40,000 | $0.83 | $33K | 416,250 |
| 2026-01-07 | SCHECHTER JONATHAN Director | Purchase | +20,000 | $0.84 | $17K | 192,500 |
| 2026-01-06 | Silverman Joshua CEO and President | Purchase | +30,000 | $0.79 | $24K | 376,250 |
| 2026-01-06 | SCHECHTER JONATHAN Director | Purchase | +20,000 | $0.79 | $16K | 172,500 |
| 2026-01-05 | Silverman Joshua CEO and President | Purchase | +30,000 | $0.78 | $23K | 346,250 |
| 2026-01-05 | SCHECHTER JONATHAN Director | Purchase | +20,000 | $0.78 | $16K | 152,500 |
| 2025-12-12 | WEINSTEIN ROBERT Director | Grant or award | +75,000 | 75,000 | ||
| 2025-12-12 | WEINSTEIN ROBERT Director | Shares withheld for taxes | −33,750 | $1.02 | $34K | 41,250 |
| 2025-12-12 | WALKER WAYNE REMELL Director | Grant or award | +37,500 | 37,500 | ||
| 2025-12-12 | WALKER WAYNE REMELL Director | Shares withheld for taxes | −16,875 | $1.02 | $17K | 20,625 |
| 2025-12-12 | Silverman Joshua CEO and President | Grant or award | +575,000 | 575,000 | ||
| 2025-12-12 | Silverman Joshua CEO and President | Shares withheld for taxes | −258,750 | $1.02 | $264K | 316,250 |
Page 1 of 2 · 40 trades